Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Effect of Deer Antler Extracts from Various Origins and Parts on the Hemopoietic Activity

녹용의 품종에 따른 조혈작용 비교연구

  • Lee, Hyo-Jeong (Department of Oncology, Graduate School of East-West Medical Science, Kyunghee University) ;
  • Park, Jeong-Ran (Department of Oncology, Graduate School of East-West Medical Science, Kyunghee University) ;
  • Kim, Ha-Na (Department of Oncology, Graduate School of East-West Medical Science, Kyunghee University) ;
  • Ahn, Kyoo-Seok (Oriental Medical College, Kyunghee University) ;
  • Cho, Deok-Yeon (Medical College, Chungnam University) ;
  • Choi, Don-Woong (Food & Drug Administration) ;
  • Kim, Sung-Hoon (Department of Oncology, Graduate School of East-West Medical Science, Kyunghee University)
  • 이효정 (경희대학교 동서의학대학원 동서종양학과) ;
  • 박정란 (경희대학교 동서의학대학원 동서종양학과) ;
  • 김하나 (경희대학교 동서의학대학원 동서종양학과) ;
  • 안규석 (경희대학교 한의과대학) ;
  • 조덕연 (충남대학교 의과대학) ;
  • 최돈웅 (식품의약 안전청) ;
  • 김성훈 (경희대학교 동서의학대학원 동서종양학과)
  • Published : 2004.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was performed to evaluate the hemopoietic effects of 6 species of deer antlers from origins and parts in vitro. CD34 positive cells were isolated and confirmed the its population by FACS analysis. In a week liquid culture, there was any statistical significance between extracts of three parts of six species of deer antlers in the experiments as colony forming assay, proliferation assay, differentiation assay and observation of morphology. However, after 2 weeks- culture with extracts of three parts of six species of deer antlers, colonies were counted. six species of deer antlers, such as middle part of Korean nippon deer, upper part of Chinese nippon deer, upper part of Newzealand horse deer, middle part of Korea horse deer and middle part of Newzealand red deer, significantly increased the CFU-GM (colony forming unit garnulocyte-macrophage) of CD34 positive cells re1atεd to production of leucocytes such as eosinophil, basophil and neutrophil, while only middle part of Korea horse deer significantly increased the BFU-E (burst forming unit-erythroid) at 1 mg/ml seggesting progenting red blood cells (RBC). In the molecular study with CD34+ cells pretreated with cyclophosphamide, antagonist of hemopoietic activity, upper Part of Korean nippon deer and upper part of Chinese nippon deer effectively increased TPO involved in a late pathway of hematopoiesis just like in ELISA assay of IL-3, TPO and GM-CSF. Taken together, these results indicate exσacts of deer antler had some hemopoietic activity still proposing more clinical study and more basic mechanism research.

Keywords

References

  1. Suh, J.S. and Eun J.S. (1999) Phagocytic activity of ethylalcohol farction of deer antler in murin peritonealmacrophage. Biol. Paharm Bull. 22(9): 932-935 https://doi.org/10.1248/bpb.22.932
  2. Won, D.H. (1994) The review of the specification and thecompositions of velvets, Proc. Int. Symp. Cervi ParvumCornu, 12-25
  3. 식품가공협회(2000) 식품첨가물공전. 식품가공협회, 1052
  4. Testa N.G. and Molineux. G. (1993) Hemopoiesis, 37-38,Oxford University Press
  5. Kim, S. H. and Kim. M. J. (1993) Biological effects of deerantler extracts on hematopoietic system, Korean J of BRM.3(1): 23-30
  6. Bae, D. S. (1975) Efects of velvet of different levels onweight gain, feed efficiency and development of organs ofchickens. Korean J of Anim. Sci. 17: 571-576 https://doi.org/10.1126/science.17.432.571
  7. 王浴生(1983)중약약리여응용. 인민위생출판사. 1090-1994
  8. Vaziri, H., Schater, F., Wei, L., Zhu, X., Effros, R., Cohen, D.,and Harley, C.B. (1993) Loss of telomeric DNA during agingof normal and trisomy 21 human lymphocytes. Am. J. Hum.Genet., 52: 661-667
  9. Vaziri, H., Dranowska W., Allsopp, R.C., Thomas, T.E.,Harley, C.B., and Lansdorp. P.M. (1994). Evidencd for amitotic clock in human hematopoietic stem cells : loss oftelomeric DNA with age. Proc. Natl. Acad. Sci. USA. 91:9857-9860 https://doi.org/10.1073/pnas.91.21.9857
  10. Shpall, E.J. and Jones, R.B. (1994). Release of tumor cellsfrom bone marrow. Blood, 83: 623-625
  11. Flasshove, M., Banerjee, Debabraate, D., Mineishi, S., Li,M.A., Bertino, R., and Moore, M.A.S. (1995). Ex vivoexpansion and selection of human $CD34^+$ peripheral bloodprogenitor cells after introduction of a mutated dihydrofolatereductase cDNA via retroviral gene transfer, blood. 85: 566-574
  12. Schain, L., Hall, M., Jain, S., Okarma, T.B., and Lebkowski,J. (1995). Animal serum free culture of purified $CD34^+$ cellsyields expansions of multiple lineage progenitors fortarnsfusion support (Abstract). 235. 2nd international mettingof ISHAGE
  13. Bradley, T.R. and Metcal, D. (1966). The growth of mousebone marrow cells in vitro Aust. J. Exp. Biol. Med. Sci. 44:287 https://doi.org/10.1038/icb.1966.28
  14. Burgess, A.W., CAmakaris, J., and Metcalf, D. (1977). Purification and properties of 7-3. colony-stimulating factor from mouse lung-conditioned medium. J. Biol. Chem., 252: 1998
  15. Wong, G.G., Witek, J.S., and Temple, P.A. (1985). HumanGM-CSF : molecular cloning of the complementary DNAand purification of the natural and recombinanat proteins.Science, 228: 810-815 https://doi.org/10.1126/science.3923623
  16. Dexter, T.M., Allen, T.D., and Lajtha, L.G. (1977). Conditions controlling the proliferation of haematopoietic stemcells in vitro. J. Cell Phys. 91: 335 https://doi.org/10.1002/jcp.1040910303
  17. Gartner, S. and Kaplan, H.S. (1980). Long-term culture ofhuman bone marrow cells. Proc. Natl. Acad. Sci. USA. 77:4756-4759 https://doi.org/10.1073/pnas.77.8.4756
  18. Moore, M.A.S. (1991). Clinical implications of positive andnegative hematopoitic stem cell regulators. Blood, 78: 1
  19. Moore, M.A.S. (1991). The furture of cytokine combinationtherapy. Cancer, 67: 2718-2716
  20. Sheridan, W.R., Gegley, C.G., and Jutter, C. (1992). Effect ofperipheral-blood progenitor cells mobilzed by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.Lancet. 339: 640-644 https://doi.org/10.1016/0140-6736(92)90795-5
  21. Shapall, E.J., Jones, R.B., and Bearman, S.I. (1994).Transplantation of enriched CD34 positive autologousmarrow into breast cancer patients following high-dosechemotherapy : influence of CD34-positive peripheral-bloodprogenitors and growth factors on engraftment. J. Clin.Oncol., 12: 28-36 https://doi.org/10.1200/JCO.1994.12.1.28
  22. Brugger, W., Henshler, R., Heinfeld, S., Berenson, R.J.,Mertelsman., R., and Kanz, L.(1994) : Positively selectedautologous blood $CD34^+$ cells unseparated peripheral bloodprogenitor cells mediate identical hematopoietic engraftmentafter high-dose VP-16, ifosfamide, carboplatin, andepirubicin. Blood, 84: 1421-1426
  23. Srour, E.R., Brandt, J.E., Briddell, R.A., Grigsby, S.,Leemhuis, T., and Hoffman, R. (1993). Lomg-term generation and expansion of human primitive hematopoirticprogrnitor cells in vitro. Blood. 81: 661-669
  24. Koller, M.R., Emerson, S.G., and Palsson, B.O.(1993) Largescale expansion of human stem and progenitor cells frombone marrow mononuclear cells in continuous perfusioncultures. Blood. 82: 378-384
  25. Haylock, D.N., To, L.b., Dowse, T.L., Juttner, C.A., andSimmons, P.J. (1992). Ex vivo expansion and maturation ofperipheral blood $CD34^+$ cells into the myloid lineage. Blood,80: 1405-1412
  26. Henschler, R., Brugger, W., Luft, T., Frey, T., Mertelsmann,R., and Kanz, L. (1994) Maintenenace of transplanatationpotential in ex vivo expanded $CD34^+$-se1ected humanperipheral blood progenitor cells. Blood. 84: 2898-2903
  27. Sato, N., Sawada, K., Tarumi, T., Leko, M., Yasukouchi, T., Yamaguchi, M., Takahashi, T.A., Sikiguchi, S., and Koike, T. (1993). In vitro expansion of human peripheral blood $CD34^+$ cells. Blood. 82: 3600-3609
  28. Brugger, W., Mocklin, W., Heimfeld, S., Berenson, R.J.,Mertelsman, R., and Kanz, L. (1993). EX vivo expansion ofenriched peripheral blood CD34+ progenitor cells by stemcell factor, inter1eukin-1(IL-1), IL-6, IL-3, interferon-r, anderythropoietin. Blood. 81: 2579-1584
  29. Shapiro, F, Yao, T.J., Raptis, G., Reich, L., Norton, L., andMoore, M.A.S. (1994). Optimization of conditions for exvivo expansion of $CD34^+$ cells from patients with stage IVbreast cancer. Blood. 84: 3567-3574
  30. Hami, L., Greer, G., Greenfield, D., Steele, A., and Shapall,E. (1995) The ex-vivo expansion of CD34 purified cordblood progenitor cells (Abstract). 2nd International Meetingof ISHAGE, Proceeding. 235
  31. Brandt, J., Briddell, R.A., Srour, E.F., Leemhuis, T.B., andHoffman, R. (1992). Role of c-kit lugand in the expansion ofhuman hematopoietic progenitor cells, Blood. 79: 634-641
  32. Brugger, W., Heimfeld, S., Berenson, R., Mertelsmann, R., and Kanz, L. (1995) Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333: 283-287 https://doi.org/10.1056/NEJM199508033330503
  33. Miltenyi, S., Meuller, W., Weichel, W., and Radbruch, A.(1990). High gradient magnetic cell separation with MACS.Cytometry, 11: 231-238 https://doi.org/10.1002/cyto.990110203
  34. Itoh K., et al. (1989). Reproducible establishment ofhemopoietic supportive cell lines from murine bone marrow.Exp. Hematol, 17: 145
  35. Issad C., et al. (1993). A murine stroma cell line allows theproiferation of very primitive human $CD34^{+ +}$/CD38-progenitor cells in long-term cultures and semisoid assays.Blood. 81: 2916
  36. Sutherland H.J., et al. (1989). Characterization and partialpurification of human marrow cells capable of initiatinglong-term hamtopoiesis in vitro. Blood. 74: 1563